Rein Verbeke
postdoc
Ghent University Hospital / Ghent University
Gent, Belgium
Research focus is on mRNA vaccines. Happy to help with the development and characterization of mRNA-LNP vaccines or other types of nanovaccines.
My organisation
Ghent University Hospital / Ghent University
Ghent University Hospital / Ghent University
Academic institution
Gent, Belgium
About me
Dr. Rein Verbeke is a senior postdoc in the Ghent Research Group on Nanomedicines (Ghent University). His PhD focused on the design of mRNA-LNPs and the adjuvancy of mRNA vaccines. Rein continued his research on the validation of a glycolipid-adjuvanted mRNA vaccine (Galsomes) for cancer and intracellular bacterial infections. In 2022, he visited the group of Prof. Pieter Cullis, University of British Columbia, where he investigated the contribution of LNPs to the immunogenicity and reactogenicity of mRNA vaccines. Rein is also director of the Ghent Nanomedicine Center providing solutions for the formulation and in-depth characterization of bio-therapeutics in nanoparticles. www.nanomedicinecentre.com
Skills
- preclinical testing
- Analytical methods
- mRNA vaccine design
Interests
- mRNA
- LNP
- cancer vaccines